D. Dart

发表

The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment.

S. Picksley, D. Dart, P. Cooper, 2004, International journal of oncology.

Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein

S. Picksley, D. Dart, Maqsood S Mansoor, 2001 .

AR mRNA stability is increased with AR-antagonist resistance via 3′UTR variants

W. Jiang, W. Jiang, D. Dart, 2019, Endocrine connections.

Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity In Vitro and Tissue Selectivity In Vivo

D. Dart, A. Westwell, Wenguo Jiang, 2018, Molecular Cancer Therapeutics.

Overexpression of Activin Receptor-like Kinase 7 in Breast Cancer Cells Is Associated with Decreased Cell Growth and Adhesion.

F. Su, D. Dart, Wenguo Jiang, 2017, Anticancer research.

Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma

W. Jiang, D. Dart, C. Hao, 2019, Genes.

Androgens have Forgotten and Emerging Roles Outside of their Reproductive Functions, with Implications for Diseases and Disorders

D. Dart, D. A. Dart, 2014 .

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.

B. Spencer‐Dene, C. Robson, D. Mann, 2011, Cancer research.

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

D. Dart, S. Gamble, J. Waxman, 2007, Oncogene.

Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonists.

D. Dart, L. Davies, A. Westwell, 2019, European journal of medicinal chemistry.